Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )
15 Apr 2019

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies

Dr James Gulley - National Cancer Institute, Bethesda, USA
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )
15 Apr 2019

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
15 Apr 2019

TATTON: Updated results for patients with EGFR-mutant NSCLC

Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA
Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Apr 2019

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Prof Shoba Navai - Baylor College of Medicine, Houston, USA
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )
11 Apr 2019

Umbralisib shows early promise for patients with marginal zone lymphoma

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
11 Apr 2019

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
11 Apr 2019

Gilteritinib improved survival for patients with acute myeloid leukaemia

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
11 Apr 2019

New developments in soft tissue and bone sarcoma research

Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands
New developments in soft tissue and bone sarcoma research ( Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands )
21 Mar 2019

Latest updates in melanoma research

Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands
Latest updates in melanoma research ( Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Mar 2019

Gynaecological cancer: Where are we now?

Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019